Subgroup analyses from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trialBMC CANCERIF3.42024-07-230OAAI
Unresectable biliary tract cancer: Current and future systemic therapy无法切除的胆道癌: 当前和未来的全身治疗EUROPEAN JOURNAL OF CANCERIF7.12024-05-014OA
Effectiveness, safety and quality of life of trifluridine/tipiracil in pretreated patients with metastatic colorectal cancer: Real-world data from the noninterventional TACTIC study in GermanyINTERNATIONAL JOURNAL OF CANCERIF4.72023-06-015OAAI
BRCA2 abrogation triggers innate immune responses potentiated by treatment with PARP inhibitorsNATURE COMMUNICATIONSIF15.72019-07-17144OAAI
Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistanceEMBO MOLECULAR MEDICINEIF8.32019-05-2430OAAI